pms-desmopressin tablet
pharmascience inc - desmopressin acetate (desmopressin acetate trihydrate) - tablet - 0.1mg - desmopressin acetate (desmopressin acetate trihydrate) 0.1mg - pituitary
pms-desmopressin tablet
pharmascience inc - desmopressin acetate (desmopressin acetate trihydrate) - tablet - 0.2mg - desmopressin acetate (desmopressin acetate trihydrate) 0.2mg - pituitary
ddavp/desmopressin 100 micrograms/ml nasal drops solution
ferring ireland limited united drug house, magna drive magna business park, citywest road dublin 24 , ireland - desmopressin acetate - nasal drops, solution - desmopressin acetate 100 µg/ml - pituitary and hypothalamic hormones and analogues
desmopressin acetate- desmopressin acetate tablet
ncs healthcare of ky, inc dba vangard labs - desmopressin acetate (unii: xb13hyu18u) (desmopressin - unii:enr1llb0fp) - desmopressin acetate 0.2 mg - desmopressin acetate tablets are indicated as antidiuretic replacement therapy in the management of central diabetes insipidus and for the management of the temporary polyuria and polydipsia following head trauma or surgery in the pituitary region. desmopressin acetate is ineffective for the treatment of nephrogenic diabetes insipidus. patients were selected for therapy based on the diagnosis by means of the water deprivation test, the hypertonic saline infusion test, and/or response to antidiuretic hormone. continued response to desmopressin acetate can be monitored by measuring urine volume and osmolality. desmopressin acetate tablets are indicated for the management of primary nocturnal enuresis. desmopressin acetate may be used alone or as an adjunct to behavioral conditioning or other non-pharmacologic intervention. desmopressin acetate tablets are contraindicated in individuals with known hypersensitivity to desmopressin acetate or to any of the components of desmopressin acetate tablets. desmopressin a
desmopressin acetate- desmopressin acetate tablet
impax generics - desmopressin acetate (unii: xb13hyu18u) (desmopressin - unii:enr1llb0fp) - desmopressin acetate 0.1 mg - desmopressin acetate tablets are indicated as antidiuretic replacement therapy in the management of central diabetes insipidus and for the management of the temporary polyuria and polydipsia following head trauma or surgery in the pituitary region. desmopressin acetate is ineffective for the treatment of nephrogenic diabetes insipidus. patients were selected for therapy based on the diagnosis by means of the water deprivation test, the hypertonic saline infusion test, and/or response to antidiuretic hormone. continued response to desmopressin acetate can be monitored by measuring urine volume and osmolality. desmopressin acetate tablets are indicated for the management of primary nocturnal enuresis. desmopressin acetate may be used alone or as an adjunct to behavioral conditioning or other non-pharmacologic intervention. desmopressin acetate tablets are contraindicated in individuals with known hypersensitivity to desmopressin acetate or to any of the components of desmopressin acetate tablets. desmopressin a
ddavp/desmopressin 4 micrograms/ml solution for injection
ferring ireland limited united drug house, magna drive magna business park, citywest road dublin 24 , ireland - desmopressin acetate - solution for injection - desmopressin acetate 4 µg/ml - pituitary and hypothalamic hormones and analogues
desmopressin acetate- desmopressin acetate tablet
bryant ranch prepack - desmopressin acetate (unii: xb13hyu18u) (desmopressin - unii:enr1llb0fp) - desmopressin acetate 0.2 mg - desmopressin acetate tablets are indicated as antidiuretic replacement therapy in the management of central diabetes insipidus and for the management of the temporary polyuria and polydipsia following head trauma or surgery in the pituitary region. desmopressin acetate tablets are ineffective for the treatment of nephrogenic diabetes insipidus. patients were selected for therapy based on the diagnosis by means of the water deprivation test, the hypertonic saline infusion test, and/or response to antidiuretic hormone. continued response to desmopressin acetate can be monitored by measuring urine volume and osmolality. desmopressin acetate tablets are indicated for the management of primary nocturnal enuresis. desmopressin acetate tablets may be used alone or as an adjunct to behavioral conditioning or other non-pharmacologic intervention. desmopressin acetate tablets are contraindicated in individuals with known hypersensitivity to desmopressin acetate or to any of the components of desmopressin acetate tablet
ddavp/desmopressin 0.1mg tablets
ferring ireland ltd - desmopressin acetate - tablet - 0.1 milligram(s) - vasopressin and analogues; desmopressin
ddavp/desmopressin 4 micrograms/ml solution for injection
ferring ireland ltd - desmopressin acetate - solution for injection - 4 microgram(s)/millilitre - vasopressin and analogues; desmopressin
nu-desmopressin spray metered-dose pump
nu-pharm inc - desmopressin acetate - metered-dose pump - 0.1g - desmopressin acetate 0.1g - pituitary